Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  194,521 نتائج ل ""Tumor necrosis factor-alpha""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Conducting a real-world study of Tumor Necrosis factor-alpha inhibitors-induced Systemic Lupus Erythematosus based on the FAERS database.

  • Authors : He M; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, PR China.; Yang J

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/chemically induced ; Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/antagonists & inhibitors

  • Source: Scientific reports [Sci Rep] 2025 Feb 26; Vol. 15 (1), pp. 6838. Date of Electronic Publication: 2025 Feb 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Transcriptional Activity of Tumor Necrosis Factor Alpha Genes and Their Receptors in Patients with Varying Degrees of Coronary Artery Disease.

  • Authors : Potyka K; Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.; Dąbek J

Subjects: Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/genetics ; Coronary Artery Disease*/Coronary Artery Disease*/Coronary Artery Disease*/pathology ; Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/genetics

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Dec 05; Vol. 25 (23). Date of Electronic Publication: 2024 Dec 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Relationships among tumor necrosis factor-alpha levels, beta-amyloid accumulation, and hippocampal atrophy in patients with late-life major depressive disorder.

  • Authors : Ho SK; Department of Psychiatry, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Hsiao IT

Subjects: Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/diagnostic imaging ; Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/metabolism ; Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/pathology

  • Source: Brain and behavior [Brain Behav] 2024 Sep; Vol. 14 (9), pp. e70016.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101570837 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries.

  • Authors : Pocino K; Unità Operativa Complessa di Patologia Clinica, Ospedale San Pietro Fatebenefratelli, 00189 Rome, Italy.; Carnazzo V

Subjects: Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/metabolism ; Skin*/Skin*/Skin*/metabolism ; Skin*/Skin*/Skin*/pathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 16; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

Tumor Necrosis Factor-Alpha Modulates Expression of Genes Involved in Cytokines and Chemokine Pathways in Proliferative Myoblast Cells.

  • Authors : Alvarez AM; Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, Sao Paulo 05503-900, SP, Brazil.; Reproduction Group, Pharmacy Department, School of Pharmaceutical and Food Sciences, University of Antioquia-UdeA, Medellín 050010, Colombia.

Subjects: Myoblasts*/Myoblasts*/Myoblasts*/metabolism ; Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/metabolism ; Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/pharmacology

  • Source: Cells [Cells] 2024 Jul 08; Vol. 13 (13). Date of Electronic Publication: 2024 Jul 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

×
Academic Journal

Therapeutic Outcomes of Non-Infectious Scleritis Treated with Tumor Necrosis Factor-Alpha Inhibitors.

  • Authors : Brown JE; Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, USA.; Thomas AS

Subjects: Scleritis*/Scleritis*/Scleritis*/drug therapy ; Scleritis*/Scleritis*/Scleritis*/diagnosis ; Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/Tumor Necrosis Factor-alpha*/antagonists & inhibitors

  • Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Aug; Vol. 32 (6), pp. 1017-1023. Date of Electronic Publication: 2023 Apr 12.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis.

  • Authors : Kamel FZ; Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.; Hoseiny HAM

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/genetics ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/genetics

  • Source: BMC immunology [BMC Immunol] 2024 Jul 04; Vol. 25 (1), pp. 40. Date of Electronic Publication: 2024 Jul 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

تفاصيل العنوان

×
Report

A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy (COSMOS)

  • Source: Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis

تفاصيل العنوان

×
  • 1-10 ل  194,521 نتائج ل ""Tumor necrosis factor-alpha""